Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePDS Biotechnology Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.01 at 11:40 AM on Oct 05, then ran to $1.35 +34% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is PDSB down today? It is at $1.02 (-4.37%), and our scanner flagged it 520 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PDSB spikes, and full due diligence on PDSB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PDSB 520 times in the last 30 days. Create a free account to track $PDSB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PDSB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PDSB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Glover Stephen C. Director | Bought (open market) | +15K 0.02% of company | added 24% | 79K | $25K at $1.66 | Feb 28, 25 |
Freitag Gregory Gene Director | Bought (open market) | +15K 0.02% of company | added 33% | 61K | $25K at $1.66 | Feb 28, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PDSB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PDSB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PDSB last traded at $1.02, down 4.37% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
PDS Biotechnology Corporation Common Stock (PDSB) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PDSB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PDSB 520 times in the last 30 days.
PDSB (PDS Biotechnology Corporation Common Stock) trades on XNAS, with a market cap of about $74M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PDSB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PDSB discussion
Sign in to ask a question or join the discussion.